Lombard Odier Asset Management (USA)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-650
Closed -$506K 342
2024
Q1
$506K Buy
+650
New +$463K 0.01% 246
2021
Q1
Sell
-1,622
Closed -$274K 361
2020
Q4
$274K Buy
+1,622
New +$242K 0.01% 230
2020
Q2
Sell
-17,200
Closed -$2.39M 274
2020
Q1
$2.39M Buy
+17,200
New +$2.36M 0.25% 109

Other funds holding LLY

Lombard Odier Asset Management (USA)'s LLY Position: Q2 2024 in Review

Lombard Odier Asset Management (USA) sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 650 shares — an estimated $506K sold.

Lombard Odier Asset Management (USA) first reported a position in LLY in Q1 2020 and held it in 3 quarters. The position peaked at $2.39M in Q1 2020. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Lombard Odier Asset Management (USA) reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 650 Eli Lilly shares in Q2 2024, an estimated $506K.
  • Lombard Odier Asset Management (USA) first reported a position in Eli Lilly in Q1 2020 and held it in 3 quarters.
  • Lombard Odier Asset Management (USA)'s Eli Lilly position peaked at $2.39M in Q1 2020.
  • 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2024, filed 14 Aug 2024.